This application constitutes a renewal on the part of the University of California/Los Angeles (UCLA) for a Center for AIDS Research (CFAR) grant. This grant will fund activities and programs conducted by the UCLA CFAR/AIDS Institute. The UCLA AIDS Institute was established in 1992 to coordinate all AIDS research, clinical and educational activities at the University and its seven affiliated teaching hospitals under one central administration. This renewal application includes core services and activities described herein that are designed to advance knowledge of HIV/AIDS through the basic, clinical, and behavioral sciences. The overall goal is to develop therapies and approaches to prevent and ultimately eliminate the threat of HIV/AIDS. The CFAR/AIDS Institute consists of more than 140 faculty investigators responsible for over 200 research projects that encompass various aspects of HIV/AIDS biology, clinical studies, and behavioral science investigations. UCLA has consistently been ranked among the top five institutions by various sources for its excellence in AIDS research, education and teaching, and clinical programs. Metropolitan Los Angeles is a major epicenter for the AIDS epidemic and one of the most culturally diverse regions in the nation. The role of the CFAR/AIDS Institute is to foster collaboration and build linkages both within and outside the university. The action plan for the first year of requested support, July 2003 through June 2004, is summarized as follows. The CFAR/AIDS Institute plans to continue supporting 10 of the 12 cores originally funded by the previous CFAR: Administrative Core, Developmental Core, Virology/BSL3 Tissue Culture Core, Flow Cytometry/Cell Sorting Core, Mouse/Human Chimera Core, Gene and Cellular Therapy Core, Mucosal Immunology Core, International Activities Core, Behavioral Adherence, Recruitment and Retention Core, and a Biostatistics Core. Based upon changing epidemiology, needs assessments, strategic planning and revised long and short-term goals, two cores were eliminated and a Clinical Translation Core was added to improve both local and international outreach and capacity-building efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI028697-14
Application #
6600105
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Program Officer
Namkung, Ann S
Project Start
1991-09-01
Project End
2007-12-31
Budget Start
2003-07-01
Budget End
2003-12-31
Support Year
14
Fiscal Year
2003
Total Cost
$842,284
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Seang, Sophie; Kelesidis, Theodoros; Huynh, Diana et al. (2018) Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses 34:39-45
Kojima, Noah; Klausner, Jeffrey D (2018) Fight Fire With Fire: Innovations to Address Syphilis Among Men Who Have Sex With Men. Sex Transm Dis 45:e85-e86
Black, David S; Cole, Steve W; Christodoulou, Georgia et al. (2018) Genomic mechanisms of fatigue in survivors of colorectal cancer. Cancer 124:2637-2644
Ziyad, Safiyyah; Riordan, Jesse D; Cavanaugh, Ann M et al. (2018) A Forward Genetic Screen Targeting the Endothelium Reveals a Regulatory Role for the Lipid Kinase Pi4ka in Myelo- and Erythropoiesis. Cell Rep 22:1211-1224
Walser, Tonya C; Jing, Zhe; Tran, Linh M et al. (2018) Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78:1986-1999
Fulcher, Jennifer A; Shoptaw, Steven; Makgoeng, Solomon B et al. (2018) Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus. J Acquir Immune Defic Syndr 78:119-123
Chua, Bernadette Anne; Ngo, Jamie Ann; Situ, Kathy et al. (2018) Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515:176-190
Kojima, Noah; Klausner, Jeffrey D (2018) Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection. AIDS 32:272-275
Khamaikawin, Wannisa; Shimizu, Saki; Kamata, Masakazu et al. (2018) Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 9:23-32
Allyn, P R; O'Malley, S M; Ferguson, J et al. (2018) Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection. Int J STD AIDS 29:334-340

Showing the most recent 10 out of 942 publications